FENC Stock Price
$6.78 (+0.99%)
At 2024-05-30 20:00:00 ESTFennec Pharmaceuticals Inc
(NASDAQ:FENC) 
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced heari...
Website: http://www.fennecpharma.com
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology
Next Earnings Date: 2023-08-10
FENC - Daily
Date: 2024-05-31, O: 6.82, H: 6.86, L: 6.67, C: 6.78, Volume: 101,374
10EMA: 7.1520EMA: 7.7050EMA: 8.67100EMA: 9.15200EMA: 9.23
10EMA: 7.1520EMA: 7.7050EMA: 8.67100EMA: 9.15200EMA: 9.23
NASDAQ:FENC Stock Key Statistics
| Basic Info: | |||
| Market Cap: | 178.17M | Exchange: | NASDAQ |
| Shares Outstanding: | 27,099,900 | Number of Employees: | 4 |
| Advanced Info: | |||
| Beta: | 0.4 | Return on Equity (ROE) ttm: | 181.00% |
| Return on Assets (ROA) ttm: | -66.00% | Earnings per Share (EPS) ttm: | -0.6 |
| Book value per Share: | -0.43 | Cash per Share: | 0.5 |
| Current ast per Share: | 1 | ||
| Key Ratios: | |||
| P/E ttm: | -10.07 | P/E forward: | 21.92 |
| P/E ttm high: | -9.47 | P/E ttm low: | -17.92 |
| P/S ttm: | 8.28 | P/B ttm: | 53.16 |
| P/FCF ttm: | -10.34 | PEG ratio: | |
| Cash Ratios: | |||
| Cash Ratio ttm: | 1.76 | Quick Ratio ttm: | 2.92 |
| Current Ratio ttm: | 3.56 | ||
| Margins: | |||
| Gross Margin ttm: | 94.06% | EBITDA Margin ttm: | -60.45% |
| Operating Margin ttm: | -18.70% | Net Income Margin ttm: | -82.24% |
| Dividends: | |||
| Trailing Dividend yield: | Forward Dividend yield: | ||
| Payout Ratio ttm: | Ex-Dividend date: | None | |
| Target Prices: | |||
| Target Price High: | 18 USD | Target Price Low: | 15 USD |
| Target Price Mean: | 16.33 USD | Number of Analysts: | 6 |
| Debt: | |||
| Debt Ratio ttm: | 1.11 | Debt to Equity ttm: | -2.56 |
| Total Net Debt: | 16.38M | ||
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.